-
1
-
-
70350568827
-
New antiplatelet agents: Why they are needed
-
M. Franchini, and P.M. Mannucci New antiplatelet agents: why they are needed Eur J Intern Med 20 2009 733 738
-
(2009)
Eur J Intern Med
, vol.20
, pp. 733-738
-
-
Franchini, M.1
Mannucci, P.M.2
-
3
-
-
0032560732
-
Hemostatic drugs
-
P.M. Mannucci Hemostatic drugs N Engl J Med 339 1998 245 253
-
(1998)
N Engl J Med
, vol.339
, pp. 245-253
-
-
Mannucci, P.M.1
-
4
-
-
34249821653
-
Prevention and treatment of major blood loss
-
P.M. Mannucci, and M. Levi Prevention and treatment of major blood loss N Engl J Med 356 2007 2301 2311
-
(2007)
N Engl J Med
, vol.356
, pp. 2301-2311
-
-
Mannucci, P.M.1
Levi, M.2
-
5
-
-
71749087343
-
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: A retrospective analysis of nationwide registry data
-
R. Sorensen, M.L. Hansen, S.Z. Abildstrom, A. Hvelplund, C. Andersson, and C. Jorgensen Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data Lancet 374 2009 1967 1974
-
(2009)
Lancet
, vol.374
, pp. 1967-1974
-
-
Sorensen, R.1
Hansen, M.L.2
Abildstrom, S.Z.3
Hvelplund, A.4
Andersson, C.5
Jorgensen, C.6
-
6
-
-
29544437848
-
Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes
-
K.P. Alexander, A.Y. Chen, M.T. Roe, L.K. Newby, C.M. Gibson, and N.M. Allen-LaPointe Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes JAMA 294 2005 3108 3116
-
(2005)
JAMA
, vol.294
, pp. 3108-3116
-
-
Alexander, K.P.1
Chen, A.Y.2
Roe, M.T.3
Newby, L.K.4
Gibson, C.M.5
Allen-Lapointe, N.M.6
-
7
-
-
68749096118
-
Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction
-
P. Willis, and M.D. Voeltz Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction Am J Cardiol 104 2009 34C 38C Suppl
-
(2009)
Am J Cardiol
, vol.104
-
-
Willis, P.1
Voeltz, M.D.2
-
8
-
-
33747599590
-
Adverse impact of bleeding on prognosis in patients with acute coronary syndromes
-
J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782
-
(2006)
Circulation
, vol.114
, pp. 774-782
-
-
Eikelboom, J.W.1
Mehta, S.R.2
Anand, S.S.3
Xie, C.4
Fox, K.A.5
Yusuf, S.6
-
9
-
-
68249154903
-
Clinical implications and management of bleeding events in patients with acute coronary syndromes
-
L. De Luca, G. Casella, M. Lettino, G. Fradella, V. Toschi, and M.R. Conte Clinical implications and management of bleeding events in patients with acute coronary syndromes J Cardiovasc Med 10 2009 677 686
-
(2009)
J Cardiovasc Med
, vol.10
, pp. 677-686
-
-
De Luca, L.1
Casella, G.2
Lettino, M.3
Fradella, G.4
Toschi, V.5
Conte, M.R.6
-
10
-
-
27144475755
-
Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes
-
DOI 10.1016/j.amjcard.2005.06.056, PII S0002914905012555
-
S.V. Rao, K. O'Grady, K.S. Pieper, C.B. Granger, L.K. Newby, and F. Van de Werf Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206 (Pubitemid 41505393)
-
(2005)
American Journal of Cardiology
, vol.96
, Issue.9
, pp. 1200-1206
-
-
Rao, S.V.1
O'Grady, K.2
Pieper, K.S.3
Granger, C.B.4
Newby, L.K.5
Van De Werf, F.6
Mahaffey, K.W.7
Califf, R.M.8
Harrington, R.A.9
-
11
-
-
34547801673
-
Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes
-
S.V. Rao, J.A. Eikelboom, C.B. Granger, R.A. Harrington, R.M. Califf, and J.P. Bassand Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1193 1204
-
(2007)
Eur Heart J
, vol.28
, pp. 1193-1204
-
-
Rao, S.V.1
Eikelboom, J.A.2
Granger, C.B.3
Harrington, R.A.4
Califf, R.M.5
Bassand, J.P.6
-
12
-
-
37349125565
-
Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?
-
F.A. Spencer, M. Moscucci, C.B. Granger, J.M. Gore, R.J. Goldberg, and P.G. Steg Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 116 2007 2793 2801
-
(2007)
Circulation
, vol.116
, pp. 2793-2801
-
-
Spencer, F.A.1
Moscucci, M.2
Granger, C.B.3
Gore, J.M.4
Goldberg, R.J.5
Steg, P.G.6
-
13
-
-
38949108302
-
Percutaneous coronary intervention pharmacology: From a triangle to a square
-
H.L. Dauerman Percutaneous coronary intervention pharmacology: from a triangle to a square J Am Coll Cardiol 51 2008 698 700
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 698-700
-
-
Dauerman, H.L.1
-
14
-
-
4644350897
-
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes
-
S.V. Rao, J.G. Jollis, R.A. Harrington, C.B. Granger, L.K. Newby, and P.W. Armstrong Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JAMA 292 2004 1555 1562
-
(2004)
JAMA
, vol.292
, pp. 1555-1562
-
-
Rao, S.V.1
Jollis, J.G.2
Harrington, R.A.3
Granger, C.B.4
Newby, L.K.5
Armstrong, P.W.6
-
15
-
-
17744379171
-
Association of hemoglobin levels with clinical outcomes in acute coronary syndromes
-
M.S. Sabatine, D.A. Morrow, R.P. Giugliano, P.B. Burton, S.A. Murphy, and C.H. McCabe Association of hemoglobin levels with clinical outcomes in acute coronary syndromes Circulation 111 2005 2042 2049
-
(2005)
Circulation
, vol.111
, pp. 2042-2049
-
-
Sabatine, M.S.1
Morrow, D.A.2
Giugliano, R.P.3
Burton, P.B.4
Murphy, S.A.5
McCabe, C.H.6
-
16
-
-
84921622949
-
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
-
S.R. Hill, P.A. Carless, D.A. Henry, J.L. Carson, P.C. Hebert, and D.B. McClelland Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion Cochrane Database Syst Rev 2 2002 CD002042
-
(2002)
Cochrane Database Syst Rev
, vol.2
-
-
Hill, S.R.1
Carless, P.A.2
Henry, D.A.3
Carson, J.L.4
Hebert, P.C.5
McClelland, D.B.6
-
17
-
-
0026528014
-
Prudent strategies for elective red blood cell transfusion
-
H.G. Welch, K.R. Meenhan, and L.T. Goodnough Prudent strategies for elective red blood cell transfusion Ann Intern Med 116 1992 393 402
-
(1992)
Ann Intern Med
, vol.116
, pp. 393-402
-
-
Welch, H.G.1
Meenhan, K.R.2
Goodnough, L.T.3
-
18
-
-
40949102607
-
Duration of red-cell storage and complications after cardiac surgery
-
C.G. Koch, L. Li, D.I. Sessler, P. Figueroa, G.A. Hoeltge, and T. Mihaljevic Duration of red-cell storage and complications after cardiac surgery N Engl J Med 358 2008 1229 1239
-
(2008)
N Engl J Med
, vol.358
, pp. 1229-1239
-
-
Koch, C.G.1
Li, L.2
Sessler, D.I.3
Figueroa, P.4
Hoeltge, G.A.5
Mihaljevic, T.6
-
19
-
-
0031937028
-
Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: A randomized clinical trial
-
L.M.G. van de Watering, J. Hermans, J.G. Houbiers, P.J. van den Broek, H. Bouter, and F. Boer Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial Circulation 97 1998 5562 5568
-
(1998)
Circulation
, vol.97
, pp. 5562-5568
-
-
Van De Watering, L.M.G.1
Hermans, J.2
Houbiers, J.G.3
Van Den Broek, P.J.4
Bouter, H.5
Boer, F.6
-
20
-
-
2942587148
-
Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery
-
Y.M. Bilgin, L.M. van de Watering, L. Eijsman, M.I. Versteegh, R. Brand, and M.H. van Oers Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery Circulation 109 2004 2755 2760
-
(2004)
Circulation
, vol.109
, pp. 2755-2760
-
-
Bilgin, Y.M.1
Van De Watering, L.M.2
Eijsman, L.3
Versteegh, M.I.4
Brand, R.5
Van Oers, M.H.6
-
21
-
-
65349166375
-
Transfusion-related mortality: The ongoing risks of allogeneic blood transfusion and the available strategies for their prevention
-
E.C. Vamvakas, and M.A. Blajchman Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention Blood 113 2009 3406 3417
-
(2009)
Blood
, vol.113
, pp. 3406-3417
-
-
Vamvakas, E.C.1
Blajchman, M.A.2
-
22
-
-
65549123030
-
Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score
-
S. Subherwal, R.G. Bach, A.Y. Chen, B.F. Gage, S.V. Rao, and L.K. Newby Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score Circulation 119 2009 1873 1882
-
(2009)
Circulation
, vol.119
, pp. 1873-1882
-
-
Subherwal, S.1
Bach, R.G.2
Chen, A.Y.3
Gage, B.F.4
Rao, S.V.5
Newby, L.K.6
-
23
-
-
45949098057
-
Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
-
S. Schulman, Kearon C. Beyth RJ, and M.N. Levine Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 Suppl. 6 2008 257S 298S
-
(2008)
Chest
, vol.133
, Issue.SUPPL. 6
-
-
Schulman, S.1
Beyth, R.J.K.C.2
Levine, M.N.3
-
24
-
-
3042782723
-
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial
-
J.J. Ferguson, R.M. Califf, E.M. Antman, M. Cohen, C.L. Grines, and S. Goodman Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial JAMA 292 2004 45 54
-
(2004)
JAMA
, vol.292
, pp. 45-54
-
-
Ferguson, J.J.1
Califf, R.M.2
Antman, E.M.3
Cohen, M.4
Grines, C.L.5
Goodman, S.6
-
25
-
-
33645498094
-
Comparison of fondaparinux and enoxaparin in acute coronary syndromes
-
S. Yusuf, S.R. Mehta, S. Chrolavicius, R. Afzal, J. Pogue, and C.B. Granger Comparison of fondaparinux and enoxaparin in acute coronary syndromes N Engl J Med 354 2006 1464 1476
-
(2006)
N Engl J Med
, vol.354
, pp. 1464-1476
-
-
Yusuf, S.1
Mehta, S.R.2
Chrolavicius, S.3
Afzal, R.4
Pogue, J.5
Granger, C.B.6
-
26
-
-
33751221316
-
Bivalirudin for patients with acute coronary syndromes
-
G.W. Stone, B.T. McLaurin, D.A. Cox, M.E. Bertrand, A.M. Lincoff, and J.W. Moses Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
-
(2006)
N Engl J Med
, vol.355
, pp. 2203-2216
-
-
Stone, G.W.1
McLaurin, B.T.2
Cox, D.A.3
Bertrand, M.E.4
Lincoff, A.M.5
Moses, J.W.6
-
27
-
-
44249122195
-
Bivalirudin during primary PCI in acute myocardial infarction
-
G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, and D. Dudek Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
-
(2008)
N Engl J Med
, vol.358
, pp. 2218-2230
-
-
Stone, G.W.1
Witzenbichler, B.2
Guagliumi, G.3
Peruga, J.Z.4
Brodie, B.R.5
Dudek, D.6
-
28
-
-
0001074389
-
Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid
-
L. Andersson, I.M. Nilsson, J.E. Nilehn, U. Hedner, B. Granstrand, and B. Melander Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid Scand J Haematol 2 1965 230 247
-
(1965)
Scand J Haematol
, vol.2
, pp. 230-247
-
-
Andersson, L.1
Nilsson, I.M.2
Nilehn, J.E.3
Hedner, U.4
Granstrand, B.5
Melander, B.6
-
29
-
-
0016742118
-
Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-aminocarboxylic acids
-
S. Thorsen Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-aminocarboxylic acids Biochim Biophys Acta 393 1975 55 65
-
(1975)
Biochim Biophys Acta
, vol.393
, pp. 55-65
-
-
Thorsen, S.1
-
30
-
-
0035230145
-
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
-
D.A. Henry, A.J. Moxey, P.A. Carless, D. O'Connell, B. McClelland, and K.M. Henderson Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion Cochrane Database Syst Rev 1 2001 CD001886
-
(2001)
Cochrane Database Syst Rev
, vol.1
-
-
Henry, D.A.1
Moxey, A.J.2
Carless, P.A.3
O'Connell, D.4
McClelland, B.5
Henderson, K.M.6
-
31
-
-
0020678186
-
Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs
-
H. Fritz, and G. Wunderer Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs Arzneimittelforschung 33 1983 479 494
-
(1983)
Arzneimittelforschung
, vol.33
, pp. 479-494
-
-
Fritz, H.1
Wunderer, G.2
-
32
-
-
0024811381
-
Aprotinin concentrations effective for the inhibition of tissue kallikrein and plasma kallikrein in vitro and in vivo
-
H. Hoffmann, M. Siebeck, O. Thetter, M. Jochum, and H. Fritz Aprotinin concentrations effective for the inhibition of tissue kallikrein and plasma kallikrein in vitro and in vivo Adv Exp Med Biol 247B 1989 35 42
-
(1989)
Adv Exp Med Biol
, vol.247
, pp. 35-42
-
-
Hoffmann, H.1
Siebeck, M.2
Thetter, O.3
Jochum, M.4
Fritz, H.5
-
33
-
-
44349089188
-
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery
-
D.A. Fergusson, P.C. Hebert, C.D. Mazer, S. Fremes, C. MacAdams, and J.M. Murkin A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 2008 2319 2331
-
(2008)
N Engl J Med
, vol.358
, pp. 2319-2331
-
-
Fergusson, D.A.1
Hebert, P.C.2
Mazer, C.D.3
Fremes, S.4
MacAdams, C.5
Murkin, J.M.6
-
34
-
-
58849137661
-
The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: A meta-analysis
-
D. Henry, P. Carless, D. Fergusson, and A. Laupacis The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis CMAJ 180 2009 183 193
-
(2009)
CMAJ
, vol.180
, pp. 183-193
-
-
Henry, D.1
Carless, P.2
Fergusson, D.3
Laupacis, A.4
-
35
-
-
37449034020
-
The use of desmopressin in open-heart surgery
-
M. Cattaneo The use of desmopressin in open-heart surgery Haemophilia 14 S1 2008 40 47
-
(2008)
Haemophilia
, vol.14
, Issue.S1
, pp. 40-47
-
-
Cattaneo, M.1
-
36
-
-
0028885045
-
The effect of desmopressin on reducing blood loss in cardiac surgery - A meta-analysis of double-blind, placebo-controlled trials
-
M. Cattaneo, A.S. Harris, U. Stromberg, and P.M. Mannucci The effect of desmopressin on reducing blood loss in cardiac surgery - a meta-analysis of double-blind, placebo-controlled trials Thromb Haemost 74 1995 1064 1070
-
(1995)
Thromb Haemost
, vol.74
, pp. 1064-1070
-
-
Cattaneo, M.1
Harris, A.S.2
Stromberg, U.3
Mannucci, P.M.4
-
37
-
-
0028079871
-
Meta-analysis of prophylactic drug treatment in the prevention of postoperative bleeding
-
S.E. Fremes, B.I. Wong, E. Lee, R. Mai, G.T. Christakis, and R. Mc Lean Meta-analysis of prophylactic drug treatment in the prevention of postoperative bleeding Ann Thorac Surg 58 1994 1580 1588
-
(1994)
Ann Thorac Surg
, vol.58
, pp. 1580-1588
-
-
Fremes, S.E.1
Wong, B.I.2
Lee, E.3
Mai, R.4
Christakis, G.T.5
Mc Lean, R.6
-
38
-
-
0033524140
-
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints
-
M. Levi, M.E. Cromheecke, E. de Jonge, M.H. Prins, B.J. de Mol, and E. Briët Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints Lancet 354 1999 1940 1947
-
(1999)
Lancet
, vol.354
, pp. 1940-1947
-
-
Levi, M.1
Cromheecke, M.E.2
De Jonge, E.3
Prins, M.H.4
De Mol, B.J.5
Briët, E.6
-
39
-
-
10244270631
-
The use of recombinant factor VIIa in the treatment of bleeding disorders
-
H.R. Roberts, D.M. Monroe, and G.C. White The use of recombinant factor VIIa in the treatment of bleeding disorders Blood 104 2004 3858 3864
-
(2004)
Blood
, vol.104
, pp. 3858-3864
-
-
Roberts, H.R.1
Monroe, D.M.2
White, G.C.3
-
40
-
-
0036464599
-
Mechanism of factor VIIa-dependent coagulation in hemophilia blood
-
S. Butenas, K.E. Brummel, R.F. Branda, S.G. Paradis, and K.G. Mann Mechanism of factor VIIa-dependent coagulation in hemophilia blood Blood 99 2002 923 930
-
(2002)
Blood
, vol.99
, pp. 923-930
-
-
Butenas, S.1
Brummel, K.E.2
Branda, R.F.3
Paradis, S.G.4
Mann, K.G.5
-
41
-
-
0027302704
-
The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor
-
H. ten Cate, K.A. Bauer, M. Levi, T.S. Edgington, R.D. Sublett, and S. Barzegar The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor J Clin Invest 92 1993 1207 1212
-
(1993)
J Clin Invest
, vol.92
, pp. 1207-1212
-
-
Ten Cate, H.1
Bauer, K.A.2
Levi, M.3
Edgington, T.S.4
Sublett, R.D.5
Barzegar, S.6
-
42
-
-
0036090268
-
Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A
-
T. Lisman, L.O. Mosnier, T. Lambert, E.P. Mauser-Bunschoten, J.C. Meijers, and H.K. Nieuwenhuis Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A Blood 99 2002 175 179
-
(2002)
Blood
, vol.99
, pp. 175-179
-
-
Lisman, T.1
Mosnier, L.O.2
Lambert, T.3
Mauser-Bunschoten, E.P.4
Meijers, J.C.5
Nieuwenhuis, H.K.6
-
43
-
-
17044405174
-
Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review
-
M. Levi, M. Peters, and H.R. Buller Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review Crit Care Med 33 2005 883 890
-
(2005)
Crit Care Med
, vol.33
, pp. 883-890
-
-
Levi, M.1
Peters, M.2
Buller, H.R.3
-
44
-
-
33747193523
-
Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation
-
R. Altman, A. Scazziota, M. De Lourdes Herrera, and C. Gonzalez Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation J Thromb Haemost 4 2006 2022 2027
-
(2006)
J Thromb Haemost
, vol.4
, pp. 2022-2027
-
-
Altman, R.1
Scazziota, A.2
De Lourdes Herrera, M.3
Gonzalez, C.4
-
45
-
-
34250193640
-
The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders
-
M.C. Poon The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders Transfus Med Rev 21 2007 223 236
-
(2007)
Transfus Med Rev
, vol.21
, pp. 223-236
-
-
Poon, M.C.1
|